Propionic acid and neurofilament light chain in multiple sclerosis
Clicks: 1
ID: 319660
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #372 of 374 articles by views in Brain research
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 374 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
This scientific commentary refers to ‘Propionic acid in multiple sclerosis: a phase 2b, double blind, randomized placebo-controlled trial’ by Moser et al. (https://doi.org/10.1093/brain/awag099).
| Reference Key |
openalex_W7167423002
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Sofia Sandgren, David Leppert, Jens Kühle |
| Journal | Brain research |
| Year | 2026 |
| DOI |
10.1093/brain/awag192
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.